United States Beri Beri Treatment Market to Grow at 7% CAGR, Driven by Nutritional Disorder Management & Therapeutic Development

Leander, Texas and Tokyo, Japan - Dec.04.2025
As per DataM intelligence research report" Beri Beri Treatment Market is estimated to reach at a high CAGR 7% during the forecast period (2024-2031)." Nutrition awareness and early detection efforts are driving demand for targeted beri beri treatments.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/beri-beri-treatment-market?Prasad

United States: Recent Industry Developments

✅ In November 2025, a U.S. nutraceutical company launched a high-bioavailability thiamine supplement for alcohol use disorder The product is designed to rapidly restore Vitamin B1 levels to prevent Beri Beri and Wernicke's encephalopathy It targets a high-risk population in the U.S. with a specialized medical food

✅ In September 2025, The FDA issued a warning letter to manufacturers of unapproved thiamine injections The action ensures that only safe and effective high-dose thiamine products are on the market It protects U.S. patients receiving emergency treatment for acute thiamine deficiency

✅ In July 2025, a retrospective study in a major U.S. hospital highlighted the resurgence of Beri Beri in post-bariatric surgery patients The study calls for stricter nutritional monitoring protocols for weight-loss surgery patients It raises awareness among U.S. surgeons about this preventable nutritional complication

✅ In May 2025, The National Institutes of Health (NIH) funded a study on genetic factors predisposing individuals to thiamine deficiency The research aims to understand why some people develop Beri Beri more easily than others It advances the science of personalized nutrition in the U.S.

Japan: Recent Industry Developments

✅ In October 2025, Takeda Pharmaceutical released a new educational app for elderly care facilities on preventing "hidden" Beri Beri The app helps caregivers identify subtle signs of thiamine deficiency like heart failure and edema It addresses the nutritional health of Japan's super-aging population

✅ In August 2025, Alinamin Pharmaceutical launched a "premium" Vitamin B1 drink targeting fatigued office workers The drink contains a proprietary thiamine derivative that is absorbed more efficiently by the body It reinforces the cultural staple of "genki drinks" with scientific efficacy

✅ In June 2025, The MHLW revised the Dietary Reference Intakes for Japanese people to increase recommended thiamine The revision reflects new data on the metabolic needs of the active elderly population It guides institutional food planning for schools and nursing homes in Japan

✅ In April 2025, researchers at Kyoto University discovered a link between mild thiamine deficiency and cognitive decline The study suggests that sub-clinical Beri Beri may contribute to dementia risk It highlights the importance of Vitamin B1 fortification in the Japanese diet

Beri Beri Treatment Market: Drivers
The beri beri treatment market is expanding as nutritional awareness improves and healthcare systems address deficiencies related to inadequate thiamine intake. Treatment primarily involves thiamine supplementation, dietary improvement, and management of neurological or cardiovascular complications. Rising recognition of malnutrition, chronic alcoholism, and metabolic disorders is driving demand for timely diagnosis and intervention. Advancements in nutritional therapy, fortified foods, and clinical management guidelines are supporting effective treatment strategies. Additionally, public health initiatives promoting balanced nutrition are strengthening market growth.

Collaboration among healthcare providers, nutritionists, and public health agencies is enhancing early screening and treatment programs. Growth in community healthcare services, fortified supplementation products, and hospital-based nutritional care is expanding accessibility. Emphasis on preventive healthcare, maternal nutrition, and chronic disease management is influencing treatment adoption. With rising focus on nutrition-based medicine and awareness of deficiency disorders, the beri beri treatment market is poised for steady global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/beri-beri-treatment-market?Prasad

Beri Beri Treatment Market: Major Players
Fresenius Kabi USA, LLC, GlaxoSmithKline plc, Parex Pharmaceuticals Pvt. Ltd., Solgar, EZ Melts, Bulk Supplements, DSM, AdvaCare Pharma.

Segment Covered in the Beri Beri Treatment Market:
By Type
Wet Beri Beri leads with 55% share due to higher prevalence in regions with cardiovascular complications. Dry Beri Beri holds 45%, commonly seen in chronic thiamine deficiency cases affecting the nervous system.

By Drug Type
Branded drugs dominate with 62% share, driven by quality assurance and physician preference. Generics account for 38%, supported by cost-effectiveness and increasing adoption in emerging markets.

By End-User
Hospitals lead with 50% share, providing acute care and intravenous thiamine therapy. Specialty clinics hold 30%, focusing on nutritional deficiencies and outpatient management. Other end-users contribute 20%, including community health centers and homecare providers.

Regional Analysis
Asia Pacific - 41%
Asia Pacific leads with 41% share due to higher prevalence of nutritional deficiencies and growing awareness in India, Southeast Asia, and China.

North America - 22%
North America holds 22%, supported by fortified foods, early diagnosis, and hospital-based treatment.

Europe - 20%
Europe accounts for 20%, driven by supplementation programs and treatment of chronic deficiency cases.

Latin America - 9%
Latin America contributes 9%, with growth from improving healthcare access and nutritional awareness.

Middle East & Africa - 8%
MEA holds 8%, supported by government nutrition initiatives and increasing availability of thiamine therapies.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=beri-beri-treatment-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.